"$17.96B → $707.75B by 2034" → That's the AI-in-logistics market, compounding at 44.4% a year. And in the Middle East & Africa, it's growing even faster → 50.2% CAGR, the fastest of any region globally.

But the real story isn't the market size. It's that the technology behind it is no longer a dashboard or a predictive model. It's intelligence that acts.

In our latest insight, we break down how Agentic AI is already transforming 11 operating domains across Supply Chain, Shipping & Logistics, drawn from live enterprise deployments with clients across Europe and the Middle East:

→ Customs processing: 2–4 hours → under 90 seconds

→ Transport orchestration: 8–15% cost reduction, planner productivity up 2.5–4x

→ Fleet maintenance: 25–40% less unplanned downtime

→ Freight procurement: 100% invoice audit coverage (vs. the usual 15–20% sample)

→ Warehousing: 20–40% uplift in pick productivity with no new infrastructure

→ Legacy modernisation: zero operational disruption across a $10.7B, 40-country operation

→ ESG compliance: 90% cost reduction, CSRD + CDP + #GRI + #EcoVadis from a single data input.

The ROI case is no longer speculative. McKinsey confirms 5-15% logistics cost reductions and 20-30% inventory reductions for companies deploying AI at scale.The question is no longer whether to deploy Agentic AI in supply chain. It's how quickly and with whom.

Read the article 👇

https://theagentics.co/insights/agentic-ai-for-autonomous-supply-chain-shipping-and-logistics

#AgenticAI #SupplyChain #Logistics #Shipping #AITransformation #MultiAgentSystems #ESG #CSRD #EnterpriseAI #Freight #EU #TheAgentics #Ecoratings #AINative #Sustainability

I joined Surender Selvaraj on Hawky.ai's Velocity: Performance Marketing #Podcast to break down what it really takes to become an #AINative Enterprise.Most companies think slapping on a few AI tools equals transformation. I touched upon why that’s still just rule-based automation and how the real leap happens when you move to reasoning engines and multi-agent orchestration that co-create with humans.

This podcast covers:

→ Why AI adoption ≠ AI transformation

→ The Validation First framework that lets you pilot safely and scale without catastrophic failure

→ How AI should deliver 10x productivity by multiplying human creativity... NotReplacing People

→ A new pricing model that ties our fees directly to the cost savings we deliver(yes, we literally get paid from the value we create)

This is exactly why we built The Agentics Co. as the “anti-consultancy” i.e. Strategy + Execution in one, powered by 100+ autonomous agents working in sync.

If you’re a CMO, CTO, or enterprise leader wrestling with AI transformation, we’dlove to hear your take 👇

What’s the biggest barrier you’re seeing when moving from “AI tools” to true AI Native operations?

#AINative #AITransformation #MultiAgentAI #EnterpriseAI #AgenticSystems #PerformanceMarketing

Les fabricants de médicaments génériques se trouvent à un tournant décisif : la performance ESG devient impérative sous la pression des réglementations, des exigences commerciales et des opportunités opérationnelles.

Les entreprises leaders tirent parti des plateformes ESG basées sur l’IA pour acquérir un avantage concurrentiel, tandis que celles qui accusent un retard risquent de perdre des parts de marché et d’engendrer des coûts importants.

Agentics AI, un système de modèles d’IA spécialisés, offre une solution transformatrice en optimisant les opérations, en réduisant les coûts et en renforçant la durabilité tout au long de la chaîne de valeur.

Agentics propose un système d’exploitation piloté par GenAI pour une fabrication pharmaceutique durable, privilégiant les informations et les actions en temps réel plutôt que les tableaux de bord.

La plateforme optimise la consommation d’énergie, les émissions de la chaîne d’approvisionnement et les rapports réglementaires, grâce à un cadre de déploiement basé sur la validation préalable, garantissant un retour sur investissement avant chaque phase. Cette approche surpasse les solutions de conseil et les logiciels ESG traditionnels en termes de rapidité, de couverture et de rentabilité.

Agentics offre une solution IA-ESG unique pour les médicaments génériques, intégrant plus de 100 agents spécifiques au secteur pharmaceutique, des certifications ISO et un modèle d’engagement basé sur la validation préalable et le retour sur investissement. Leur plateforme offre des résultats mesurables, automatise la collecte de données et garantit des informations ESG conformes aux exigences d'audit. Forte d'une expérience reconnue et d'une présence mondiale, Agentics permet aux entreprises d'optimiser leurs opérations, d'améliorer leur accès aux marchés et d'atteindre leurs objectifs de développement durable.

Ce podcast explique comment l'architecture d'IA d'Agentics remplace les rapports manuels et fastidieux par des données en temps réel, conformes aux exigences d'audit, sur l'ensemble de la chaîne de valeur. Grâce au déploiement d'agents d'IA spécialisés, les entreprises pharmaceutiques et les fabricants peuvent réaliser d'importantes économies opérationnelles dans des domaines tels que la consommation d'énergie, l'utilisation de solvants et la logistique de leur chaîne d'approvisionnement.

Agentics est certifiée ISO 9001:2015, ISO 14065:2020, est inscrite au Verra Carbon Registry, à NVIDIA Inception et à Microsoft for Startups.

Fabrikanten van farmaceutische generieke middelen staan voor een kritieke keerpunt, aangezien ESG-prestaties verplicht worden vanwege regelgevende druk, commerciële eisen en operationele kansen. Toonaangevende bedrijven maken gebruik van AI-gedreven ESG-platforms om concurrentievoordelen te behalen, terwijl bedrijven die achterblijven het risico lopen marktaandeel te verliezen en aanzienlijke kosten te maken.

Agentic AI, een systeem van gespecialiseerde AI-modellen, biedt een transformerende oplossing door operaties te optimaliseren, kosten te verlagen en duurzaamheid in de hele waardeketen te verbeteren.

Agentics biedt een door GenAI aangestuurd besturingssysteem voor duurzame farmaceutische productie, met de focus op realtime inzichten en acties in plaats van dashboards. Het platform optimaliseert het energieverbruik, de uitstoot van de toeleveringsketen en rapportages over regelgeving, met een validation-first implementatiekader dat ROI voor elke fase waarborgt.

Deze aanpak presteert beter dan traditioneel ESG-advies en software op het gebied van snelheid, dekking en kosteneffectiviteit. Agentics biedt een unieke Ai-ESG-oplossing voor farmaceutische generieke producten, met 100+ farmaceutische specifieke agenten, ISO-certificeringen en een Validation-First, ROI-gekoppeld engagementmodel. Hun platform levert meetbare resultaten, automatiseert gegevensverzameling en zorgt voor auditklare ESG-rapportages. Met een bewezen staat van dienst en wereldwijde aanwezigheid stelt Agentics bedrijven in staat om hun operaties te optimaliseren, de markttoegang te vergroten en duurzaamheidsdoelstellingen te bereiken. Deze podcast beschrijft hoe agentic AI-architectuur trage, handmatige rapportage vervangt door realtime, audit-klaar data over de hele waardeketen.

Door gespecialiseerde AI-agenten in te zetten, kunnen farmaceutische bedrijven en fabrikanten aanzienlijke operationele besparingen behalen op gebieden zoals energieverbruik, oplosmiddelgebruik en logistiek in de toeleveringsketen. Certificeringen en lidmaatschappen omvatten ISO 9001:2015, ISO 14065:2020, Verra Carbon Registry, NVIDIA Inception en Microsoft for Startups.

Pharmaceutical generics manufacturers face a critical juncture as ESG performance becomes mandatory due to regulatory pressures, commercial demands, and operational opportunities.

Leading companies are leveraging AI-powered ESG platforms to gain competitive advantages, while those lagging behind risk losing market share and incurring significant costs. Agentic AI, a system of specialized AI models, offers a transformative solution by optimizing operations, reducing costs, and enhancing sustainability across the value chain.

Agentics offers an GenAI-driven operating system for sustainable pharmaceutical manufacturing, focusing on real-time insights and actions rather than dashboards. The platform optimizes energy consumption, supply chain emissions, and regulatory reporting, with a validation-first deployment framework ensuring ROI before each phase. This approach outperforms traditional ESG consulting and software in speed, coverage, and cost-effectiveness.

Agentics offers a unique Ai-ESG solution for pharmaceutical generics, featuring 100+ pharma-specific agents, ISO certifications, and a Validation-First ROI-linked engagement model. Their platform delivers measurable outcomes, automates data collection, and ensures audit-ready ESG disclosures. With a proven track record and global presence, Agentics empowers companies to optimize operations, enhance market access, and achieve sustainability goals.

This podcast details how agentic AI architecture replaces slow, manual reporting with real-time, audit-ready data across the entire value chain. By deploying specialized AI agents, pharma companies and manufacturers can achieve significant operational savings in areas like energy consumption, solvent use, and supply chain logistics. 

Certifications and memberships include ISO 9001:2015, ISO 14065:2020, Verra Carbon Registry, NVIDIA Inception, and Microsoft for Startups.

De maritieme verzekeringssector bevindt zich op een cruciaal kantelpunt. Terwijl concurrenten zoals Zurich en Concirrus AI-agenten inzetten om submission-extractie en risicomodellering te automatiseren, wordt de kloof tussen early adopters en late movers dagelijks groter.

Deze podcast biedt een uitgebreid kader voor maritieme verzekeraars om te transformeren van passieve GenAI-experimenten naar actieve agentische automatisering; Met meetbare ROI in 4-12 maanden. Traditionele modellen, afhankelijk van handmatige processen en passieve analyse, maken plaats voor actieve, autonome AI-systemen.

Bij Agentics hebben we agentische AI-oplossingen ontwikkeld die zijn afgestemd op de unieke uitdagingen van maritieme verzekeraars, zoals blijkt uit ons recente voorstel aan een toonaangevende speler in de sector.

Deze podcast onderzoekt het transformerende potentieel van AI en maakt gebruik van toepassingen uit de echte wereld om te laten zien hoe het efficiëntie kan verhogen, risico's kan beperken en nieuwe inkomstenstromen kan ontsluiten. Voor C-level executives, underwriting-leiders en IT-hoofden: dit is jouw draaiboek om concurrentievoordeel te creëren via AI, terwijl je risico's beheert, naleving waarborgt en datasoevereiniteit beschermt.

Om het volledige artikel / whitepaper te lezen: https://theagentics.co/insights/transforming-marine-insurance-through-multi-agent-agentic-ai-ecosystems

The marine insurance industry stands at a critical inflection point. While competitors like Zurich and Concirrus deploy AI agents to automate submission extraction and risk modeling, the gap between early adopters and late movers widens daily. This podcast presents a comprehensive framework for marine insurers to transform from passive GenAI experimentation to active agentic automation, delivering measurable ROI in 4-12 months.

Traditional models, reliant on manual processes and passive analytics, are giving way to active, autonomous AI systems. At Agentics, we've pioneered agentic AI solutions tailored to the unique challenges of marine insurers, as demonstrated in our recent proposal to a leading player in the sector. 

This podcast explores the transformative potential of AI, drawing on real-world applications to show how it can drive efficiency, mitigate risks, and unlock new revenue streams. For C-suite executives, underwriting leaders, and IT heads: this is your playbook for building competitive advantage through AI while managing risk, ensuring compliance, and protecting data sovereignty.

To read the full article / whitepaper: https://theagentics.co/insights/transforming-marine-insurance-through-multi-agent-agentic-ai-ecosystems

Imagine this…

In a bustling oncology clinic in Mumbai, Dr. Sharma faces a problem that plagues #cancer specialists worldwide. Her next patient, a 58-year-old with metastatic colorectal cancer, arrives with a bulging folder containing five years of reports comprising of pathology results, genomic tests, imaging scans, and discharge summaries from three different hospitals. Dr. Sharma has exactly 10 minutes to mentally reconstruct this patient's complex journey before making potentially life-or-death treatment decisions.

This is oncology's information paradox: modern medicine generates more data than ever before, yet doctors have less clarity at the point of care. The result? Cognitive burnout for physicians, rushed consultations for patients, and billions in lost productivity for healthcare systems.

Enter The Agentics - Agentic AI Multi Agent Platform that's transforming this bottleneck into a competitive advantage.

This case study answers and showcases a perfect #usecase on “How Agentic AI can be used in Cancer Treatment by Oncologists?”

Agentics’ innovative deployment of #AgenticAI technology was leveraged to address a critical bottleneck in medical #oncology: the information overload paradox that compromises both clinical efficiency and patient care quality. The solution demonstrates how purpose-built AI agents can transform scattered, unstructured #clinicaldata into actionable intelligence, fundamentally reimagining the oncology consultation experience. It illustrates how agentic AI - moving beyond simple automation to collaborative, multi-agent systems - can solve complex healthcare challenges while maintaining physician authority and patient safety as paramount principles.

The podcast showcases how a multi agent Agentic AI platform developed by #TheAgentics was leveraged to create an innovative solution to streamline medical oncology workflows. By utilizing multi-agent systems, the technology converts massive amounts of unstructured clinical data, such as scanned reports and handwritten notes, into organized digital timelines for physicians. This automation addresses the information paradox in cancer care, where excessive data leads to doctor burnout and inefficient patient consultations. 

Key Outcomes

→ 90% reduction in chart-review time (from 10-15 minutes to 60 seconds)

→ Enhanced clinical reasoning through AI-highlighted progression signals and anomaly detection

→ Increased OPD (Outpatient Department) throughput enabling hospitals to serve more patients

→ Transformed patient experience through WhatsApp-based report submission and deeper consultations

→ Creation of research-ready structured oncology registries from previously unstructured data

Contact The Agentics to discuss how our Agentic AI-Powered Clinical Intelligence solution can help you transform your Medical Oncology practice through Intelligent Data Synthesis.

Email us at [email protected]. 

The podcast explores the emerging role of Generative AI as a fundamental tool for modernizing Environmental, Social, and Governance (ESG) strategies. It highlights how automated workflows and predictive analytics can resolve common corporate hurdles, such as inconsistent data quality and the high costs of regulatory compliance.

By transitioning from manual audits to real-time, self-learning systems, organizations can achieve significantly faster reporting and more accurate carbon tracking. It specifically showcases the Agentics' Ai-ESG platform, illustrating how specialized AI agents can optimize supply chains and reduce emissions across various industrial sectors.

Ultimately, the podcast discusses integrating these advanced technologies converts sustainability mandates into a competitive economic advantage and a driver for long-term resilience. These innovations are projected to contribute trillions of dollars to the global economy while accelerating the transition to a low-carbon future.

This end-to-end intelligence transforms ESG from compliance to competitive advantage, accelerating your ESG goals with 15–50% faster achievements and rapid ROI through data-driven, value-chain-wide transformations.

Our Ai-ESG Platform doesn't just report sustainability; it creates it.
Contact us to leverage GenAi to achieve your ESG Goals!

Agentics presents its latest podcast that provides quick introduction on Artificial General Intelligence (AGI) for beginners. Defining it as the critical technological leap from specialized narrow AI to systems capable of generalized, human-level reasoning and adaptation across any intellectual task, the podcast chronicles the massive investment surge into AGI research, driven by key players like OpenAI, Google DeepMind, and NVIDIA, noting that the small AGI market is projected to skyrocket to over $11 billion by 2032.

Mechanically, AGI development focuses on achieving transfer learning, emulating human cognition (System 1 and System 2 thinking), and ensuring autonomy, moving beyond the current limits of large language models like GPT-5.

While experts like Sam Altman and Elon Musk predict AGI within the next few years, the median expert forecast places the 50% chance of human-level AI closer to 2040, emphasizing the high stakes surrounding ethical governance and safety. Ultimately, the material frames AGI as an exponential breakthrough that promises radical societal abundan